These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8931481)

  • 21. Cyclin-dependent protein kinase 5 activity increases in rat brain following ischemia.
    Green SL; Kulp KS; Vulliet R
    Neurochem Int; 1997 Oct; 31(4):617-23. PubMed ID: 9308012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra.
    Henchcliffe C; Burke RE
    Neurosci Lett; 1997 Jul; 230(1):41-4. PubMed ID: 9259459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system.
    Tsai LH; Takahashi T; Caviness VS; Harlow E
    Development; 1993 Dec; 119(4):1029-40. PubMed ID: 8306873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.
    Tsai LH; Delalle I; Caviness VS; Chae T; Harlow E
    Nature; 1994 Sep; 371(6496):419-23. PubMed ID: 8090221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of neuronal cyclin-dependent kinase-5 by staurosporine and purine analogs is independent of activation by Munc-18.
    Veeranna ; Shetty KT; Amin N; Grant P; Albers RW; Pant HC
    Neurochem Res; 1996 May; 21(5):629-36. PubMed ID: 8726973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of cyclin-dependent kinases in axotomy-induced retinal ganglion cell death.
    Lefèvre K; Clarke PG; Danthe EE; Castagné V
    J Comp Neurol; 2002 May; 447(1):72-81. PubMed ID: 11967896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in cyclin-dependent protein kinase 5 (CDK5) protein levels, activity and immunocytochemistry in canine motor neuron disease.
    Green SL; Vulliet PR; Pinter MJ; Cork LC
    J Neuropathol Exp Neurol; 1998 Nov; 57(11):1070-7. PubMed ID: 9825944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens.
    Gao CY; Zakeri Z; Zhu Y; He H; Zelenka PS
    Dev Genet; 1997; 20(3):267-75. PubMed ID: 9216066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells.
    Lazaro JB; Kitzmann M; Poul MA; Vandromme M; Lamb NJ; Fernandez A
    J Cell Sci; 1997 May; 110 ( Pt 10)():1251-60. PubMed ID: 9191048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of luteinizing hormone, follicle-stimulating hormone, and epidermal growth factor on expression and kinase activity of cyclin-dependent kinase 5 in Leydig TM3 and Sertoli TM4 cell lines.
    Musa FR; Takenaka I; Konishi R; Tokuda M
    J Androl; 2000; 21(3):392-402. PubMed ID: 10819446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuronal Cdc2-like kinase: from cell cycle to neuronal function.
    Tang D; Lee KY; Qi Z; Matsuura I; Wang JH
    Biochem Cell Biol; 1996; 74(4):419-29. PubMed ID: 8960348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p67 (Munc-18), Cdk5, P-NFH and syntaxin during development of the rat cerebellum.
    Veeranna ; Grant P; Pant HC
    Dev Neurosci; 1997; 19(2):172-83. PubMed ID: 9097032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental changes of cyclin dependent kinase 5 subcellular localization in the rat cerebellum.
    Matsushita M; Matsui H; Itano T; Tomizawa K; Tokuda M; Suwaki H; Wang JH; Hatase O
    Neuroreport; 1995 Jun; 6(9):1267-70. PubMed ID: 7669983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porcine brain neurofilament-H tail domain kinase: its identification as cdk5/p26 complex and comparison with cdc2/cyclin B kinase.
    Hisanaga S; Uchiyama M; Hosoi T; Yamada K; Honma N; Ishiguro K; Uchida T; Dahl D; Ohsumi K; Kishimoto T
    Cell Motil Cytoskeleton; 1995; 31(4):283-97. PubMed ID: 7553915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Grundke-Iqbal I; Iqbal K; Bogdanovic N; Winblad B; Cowburn RF
    Brain Res; 1998 Jun; 797(2):267-77. PubMed ID: 9666145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium.
    Jordà EG; Verdaguer E; Canudas AM; Jiménez A; Garcia de Arriba S; Allgaier C; Pallàs M; Camins A
    Neuroscience; 2005; 134(3):1001-11. PubMed ID: 15979805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule.
    Kobayashi S; Ishiguro K; Omori A; Takamatsu M; Arioka M; Imahori K; Uchida T
    FEBS Lett; 1993 Dec; 335(2):171-5. PubMed ID: 8253190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small molecule cyclin-dependent kinase inhibitors protect against neuronal cell death in the ischemic-reperfused rat retina.
    Sakamoto K; Ohki K; Saito M; Nakahara T; Ishii K
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):419-25. PubMed ID: 21714634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.